NCT00318656View on ClinicalTrials.gov

24-Hour Glycemia: Rosiglitazone Versus Glimepiride In Type 2 Diabetes

PHASE4CompletedINTERVENTIONAL

Enrollment

23

Participants

Timeline

Start Date

November 30, 2005

Primary Completion Date

October 31, 2007

Study Completion Date

October 31, 2007

Conditions

Non-Insulin-Dependent Diabetes Mellitus

Interventions

DRUG

rosiglitazone-metformin fixed dose combination

DRUG

metformin + glimepiride

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY

NCT00318656 - 24-Hour Glycemia: Rosiglitazone Versus Glimepiride In Type 2 Diabetes | Biotech Hunter | Biotech Hunter